IMCG Research Team at NYU’s Perlmutter Cancer Center

Allure is proud to support The Interdisciplinary Melanoma Cooperative Group of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center. The IMCG Research Team identifies risk factors and potential markers of melanoma progression, evaluates the biologic diversity of melanoma, and establishes combination approaches for treating melanoma that integrate immunotherapeutic, chemotherapeutic and biological therapies. These common scientific interests and goals serve to foster vigorous interaction and collaboration among members of the IMCG, each of whom has a unique area of expertise in the field of melanoma. Since 2002, the IMCG has enrolled more than 2,700 patients in the effort to better understand the causes of melanoma.